← back to search

Albert C. Shaw

Yale University · US
Area of research
Immunology · Infectious Diseases
Research interest
Research interests include Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and T-cell and B-cell Immunology.
h-index
49
citations
16,175
works
188
NIH funding
primary concept
Medicine
email

Recent publications

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Communications Medicine 2026cited by 1position: middledoi
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Nature Microbiology 2026cited by 1position: middledoi
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Communications Medicine 2026cited by 0position: middledoi
Microfluidics combined with electron microscopy for rapid and high-throughput mapping of antibody–viral glycoprotein complexes
Nature Biomedical Engineering 2025cited by 7position: middledoi
A multiomics recovery factor predicts long COVID in the IMPACC study
Journal of Clinical Investigation 2025cited by 3position: middledoi
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
medRxiv 2025cited by 2position: middledoi
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
JCI Insight 2025cited by 1position: middledoi
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
Journal of Allergy and Clinical Immunology Global 2025cited by 1position: middledoi
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury
JCI Insight 2025cited by 1position: middledoi
Identification of a multi-omics factor predictive of long COVID in the IMPACC study
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Frontiers in Medicine 2025cited by 0position: middledoi
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
PubMed 2025cited by 0position: middledoi
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications 2024cited by 57position: middledoi
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
Nature Communications 2024cited by 25position: middledoi
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 15position: middledoi
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
PD-1highCXCR5–CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection
Cell Reports 2023cited by 41position: middledoi
Platelet response to influenza vaccination reflects effects of aging
Aging Cell 2023cited by 10position: lastdoi
Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
EBioMedicine 2023cited by 1position: middledoi
Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
Nature Communications 2022cited by 186position: middledoi
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
EBioMedicine 2022cited by 73position: middledoi
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Addiction Science & Clinical Practice 2022cited by 45position: middledoi
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
PLoS Biology 2022cited by 14position: middledoi
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
medRxiv 2022cited by 10position: middledoi
Delayed production of neutralizing antibodies correlates with fatal COVID-19
Nature Medicine 2021cited by 263position: middledoi
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Nature 2021cited by 260position: middledoi
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19
Nature Medicine 2021cited by 8position: middledoi
Reply to: A finding of sex similarities rather than differences in COVID-19 outcomes
Nature 2021cited by 4position: middledoi
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Nature 2020cited by 2,289position: middledoi
Perfect timing: circadian rhythms, sleep, and immunity — an NIH workshop summary
JCI Insight 2020cited by 246position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Subhasis Mohanty · Yale University6 papers (2013–2025)Akiko Iwasaki · Yale University5 papers (2016–2023)Ruth R. Montgomery · Yale University5 papers (2013–2023)Ryan D. Molony · University of Rochester Medical Center3 papers (2016–2017)Carolina Lucas · Yale University2 papers (2022–2023) · 2 papers (2013–2015)Steven H. Kleinstein · Yale University2 papers (2023–2023) · 2 papers (2022–2023)Wendy E. Walker · Texas Tech University2 papers (2015–2020)Charles S. Dela Cruz · University of Pittsburgh2 papers (2022–2023)Erol Fikrig · Yale University1 papers (2015–2015) · 1 papers (2015–2015)Laura A. Solt · University of Illinois Chicago1 papers (2020–2020)M. Catherine Muenker · Yale University1 papers (2022–2022)Yong Kong · Q Therapeutics (United States)1 papers (2017–2017) · 1 papers (2017–2017)Marija Miric · Instituto Tecnológico de Santo Domingo1 papers (2022–2022)Valter Silva Monteiro · Universidade de São Paulo1 papers (2022–2022)Michelle Louie · University of New Mexico1 papers (2025–2025)Wei Peng · Ministry of Education of the People's Republic of China1 papers (2013–2013)